Substrate specificity, inhibitors and regulation of human cytochrome P450 2D6 and implications in drug development

SF Zhou, JP Liu, XS Lai - Current medicinal chemistry, 2009 - ingentaconnect.com
CYP2D6 accounts for only a small percentage of total hepatic CYPs (100) with significant
polymorphisms. A number of drugs acting on the central nervous system and cardiovascular …
被引用次数：84 相关文章

[引用][C] Substrate Specificity, Inhibitors and Regulation of Human Cytochrome P450 2D6 and Implications in Drug Development

SF ZHOU, JP LIU, XS LAI - Current medicinal chemistry, 2009 - pascal-francis.inist.fr
Substrate Specificity, Inhibitors and Regulation of Human Cytochrome P450 2D6 and
Implications in Drug Development CNRS Inist Pascal-Francis CNRS Pascal and Francis …

[引用][C] Substrate Specificity, Inhibitors and Regulation of Human Cytochrome P450 2D6 and Implications in Drug Development

SF Zhou, JP Liu, XS Lai - Current Medicinal Chemistry, 2009 - cir.nii.ac.jp
Substrate Specificity, Inhibitors and Regulation of Human Cytochrome P450 2D6 and
Implications in Drug Development | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ …

[引用][C] Substrate specificity, inhibitors and regulation of human cytochrome P450 2D6 and implications in drug development

SF Zhou, JP Liu, XS Lai - Current Medicinal Chemistry, 2009 - research.monash.edu
Substrate specificity, inhibitors and regulation of human cytochrome P450 2D6 and implications
in drug development — Monash University Skip to main navigation Skip to search Skip to …

Substrate specificity, inhibitors and regulation of human cytochrome P450 2D6 and implications in drug development.

SF Zhou, JP Liu, XS Lai - Current Medicinal Chemistry, 2009 - europepmc.org
CYP2D6 accounts for only a small percentage of total hepatic CYPs (< 2%), but it
metabolizes approximately 25% of clinically used drugs (> 100) with significant …

Substrate Specificity, Inhibitors and Regulation of Human Cytochrome P450 2D6 and Implications in Drug Development

SF Zhou, JP Liu, XS Lai - Current Medicinal Chemistry, 2009 - hero.epa.gov
CYP2D6 accounts for only a small percentage of total hepatic CYPs (< 2%), but it
metabolizes similar to 25% of clinically used drugs (> 100) with significant polymorphisms. A …

Substrate specificity, inhibitors and regulation of human cytochrome P450 2D6 and implications in drug development

SF Zhou, JP Liu, XS Lai - Current medicinal chemistry, 2009 - pubmed.ncbi.nlm.nih.gov
CYP2D6 accounts for only a small percentage of total hepatic CYPs (< 2%), but it
metabolizes approximately 25% of clinically used drugs (> 100) with significant …

Substrate specificity, inhibitors and regulation of human cytochrome P450 2D6 and implications in drug development

S Zhou, JP Liu, X Lai - Current Medicinal Chemistry, 2009 - researchrepository.rmit.edu.au
Substrate specificity, inhibitors and regulation of human cytochrome P450 2D6 and
implications in drug development - RMIT University Logo image Limit search to: New …

Substrate specificity, inhibitors and regulation of human cytochrome P450 2D6 and implications in drug development

S Zhou, JP Liu, X Lai - Current Medicinal Chemistry, 2009 - researchrepository.rmit.edu.au
Substrate specificity, inhibitors and regulation of human cytochrome P450 2D6 and
implications in drug development - RMIT University Logo image Limit search to: New …

[引用][C] Substrate Specificity, Inhibitors and Regulation of Human Cytochrome P450 2D6 and Implications in Drug Development

SF ZHOU, JP LIU, XS LAI - Current medicinal chemistry, 2009 - Bentham